PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Feb-2022 Global Inspection Machine Markets, 2021-2028: Technological Advancements & Increasing R&D Expenditure in Pharmaceuticals and Biotechnology Industries - ResearchAndMarkets.com Businesswire
07-Feb-2022 CAR T-cell Therapy Drug Pipeline Market Research Report 2022: Insights About 300+ Companies and 300+ Pipeline Drugs - ResearchAndMarkets.com Businesswire
07-Feb-2022 Global Protease Market to 2031 - Demand for Alternatives to Synthetic Chemicals Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Feb-2022 United States Manufacturing Market 2021-2025: Historical Trends, Key Economic Indicators, Trade, Global Manufacturing Outlook, Environmental & Regulatory Factors - ResearchAndMarkets.com Businesswire
07-Feb-2022 Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs Newswire
07-Feb-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Feb-2022 Lysogene Provides Medical Update Businesswire
07-Feb-2022 TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts Businesswire
06-Feb-2022 Takeda enregistre de solides résultats pour le troisième trimestre de l'exercice 2021 et révise ses prévisions à la hausse pour l'exercice complet, reflétant une forte dynamique Businesswire
05-Feb-2022 TUESDAY DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RVNC Businesswire
05-Feb-2022 Takeda apresenta fortes resultados para o terceiro trimestre do ano fiscal de 2021 e divulga previsões para o ano inteiro refletindo forte impulso atual Businesswire
05-Feb-2022 Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Revance Therapeutics, Inc. (RVNC) Investors of Filing Deadline in Class Action Lawsuit Businesswire
05-Feb-2022 Takeda liefert im dritten Quartal FY2021 starke Ergebnisse und erhöht aufgrund der starken Dynamik die Prognose für das Gesamtjahr Businesswire
05-Feb-2022 Takeda logra resultados sólidos en el tercer trimestre del año fiscal 2021 y aumenta el pronóstico para el ejercicio completo, lo que refleja un fuerte impulso Businesswire
05-Feb-2022 REVANCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the Firm Businesswire
05-Feb-2022 BERKELEY LIGHTS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Berkeley Lights, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Feb-2022 Calidi Biotherapeutics Announces Appointment of Alfonso "Chito" Zulueta, Former President of International for Eli Lilly, to Its Board of Directors Businesswire
04-Feb-2022 Oncoinvent appoints Adrian Senderowicz MD to its Board of Directors Businesswire
04-Feb-2022 Global Inhalable Drug Delivery Devices Report 2021 - Featuring Acorda Therapeutics, Actervis and Baxter International Among Others - ResearchAndMarkets.com Businesswire
04-Feb-2022 Global Pharmaceutical Packaging Market Report 2021-2025 & 2030: International Trade & Production, Product Trends, & Demand by Product & Category - ResearchAndMarkets.com Businesswire